The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study için istatistikler
Toplam ziyaret
| views | |
|---|---|
| The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study | 3 |
Aylık toplam ziyaret
| views | |
|---|---|
| Mart 2026 | 0 |
| Nisan 2026 | 0 |
| Mayıs 2026 | 0 |
| Haziran 2026 | 0 |
| Temmuz 2026 | 0 |
| Ağustos 2026 | 0 |
| Eylül 2026 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Tam Metin/Full Text | 2 |
